Evidence map›Paper›PMID 25840598›Full record

ArticleHaematologica2015

Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma.

Anne-Sophie Michallet, Yann Guillermin, Benedicte Deau, Laure Lebras, Stephanie Harel, Sandy Amorin, Claire Reynes, Gilles Salles, Fabien Subtil, Pauline Brice

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Anne-Sophie MichalletHospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France anne-sophie.michallet@chu-lyon.fr.
Yann GuillerminHospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France.
Benedicte DeauCentre Hospitalier Cochin, Department of Hematology, Paris, France.
Laure LebrasHospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France.
Stephanie HarelCentre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France.
Sandy AmorinCentre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France.
Claire ReynesCentre Hospitalier Annecy, Department of Hematology, Pierre Bénite, France.
Gilles SallesHospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France Université de Lyon, Faculté de Médecine Lyon-Sud Charles Mérieux, Pierre Bénite, France.
Fabien SubtilHospices Civils de Lyon, Service de Biostatistique, CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Lyon, France.
Pauline BriceCentre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France.
Hôpital Lyon Sud · FRCentre Hospitalier Annecy Genevois · FRGroupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale · FRHospices Civils de Lyon · FRLaboratoire de Biométrie et Biologie Evolutive · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAnemiaAntineoplastic AgentsBrentuximab VedotinDeoxycytidineDoxorubicinDrug Administration ScheduleDrug HypersensitivityFemaleGemcitabineHodgkin DiseaseHumansImmunoconjugatesMaleNeutropeniaAntineoplastic AgentsBrentuximab VedotinDeoxycytidineDoxorubicinGemcitabineImmunoconjugatesliposomal doxorubicinPolyethylene GlycolsVinblastineVinorelbinecombined therapyHodgkin lymphomarefractorySGN 35

Identifiers

PMID25840598
PMCPMC4486239
OpenAlexW2067763617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.